Welcome To InMed Technologies

InMed Technologies is a biotech development company based in California, USA, that specializes in unique delivery systems for specific nutraceuticals, nutritional supplements and cosmeceuticals. InMed's developed technology allows for the efficient and targeted provision of solubilized compounds through the generation of very small particle sizes in an aqueous form, irrespective of their water solubility constants. This includes fat-soluble nutrients and a variety of other oils and extracts. The practical application of this technology is the development and targeted delivery of liquid formulations, including nutritional drinks, liquid supplements, and oral and topically applied sprays, gels and lotions.

Together our scientific and management team at InMed have a combined 75 years global industry experience, which has translated into authoring multiple patents, published papers, clinical trials, development of novel technologies and designing therapeutic formulations. InMed embraces a unique area of research to develop health care solutions for prospective patients, with focus on the 2 most important areas in human health: The Human Microbiome and Mitochondria.

Contact us

If you have any queries regarding InMed, or the information presented on the website, please don't hesitate to ask.

Medlab Clinical LTD

Medlab Clinical is a medical research and development facility researching and formulating novel bio-therapeutics

Products

We believe the relationship between the patient and the practitioner is paramount to good health.

A small, passionate & powerful team

The reason of the growth!

Sean Hall

Sean Hall

CEO of Medlab Clinical (AUS)
Learn More
Sean Hall

Sean Hall

CEO of Medlab Clinical (AUS)

Sean was one of the founders of FIT-BioCeuticals LTD (www.fit-bioceuticals.com.au) and through Mr. Hall's management and guidance, BioCeuticals (leading brand) expanded into a leadership role in the Australian Health Care community. Supported by novel research, FIT-BioCeuticals developed innovative products that were both patentable and coveted on the world stage.

David Rutolo

David Rutolo

Director Of Science at InMed Technologies (USA)
Learn More
David Rutolo

David Rutolo

Director Of Science at InMed Technologies (USA)

David is renowned in the US for his specialised, patented delivery systems for nutraceuticals and pharmaceuticals. He has decades of experience in manufacturing, product development and technical marketing support. David is Managing Director of lnMed Technologies in California.

Professor Luis Vitetta

Professor Luis Vitetta

Director Of Medical Research at Medlab Clinical
Learn More
Professor Luis Vitetta

Professor Luis Vitetta

Director Of Medical Research at Medlab Clinical

Luis Vitetta is Director of Medical Research at Medlab and Adjunct Professor at the University of Sydney, Sydney Medical School. Luis has deep knowledge of the science behind effective probiotics and biologic medicines. His focus on clinical research and its relevance to commercialisation informs Medlab's product portfolio.

Conferences & Presentations

InMed Technologies have been present at the following Conferences and Presentations

Patent Protected – NAFLD

Probiotic compositions and uses thereof for treatment of obesity-related disorders.

Patent Protected (AUS) – NRGBiotic

A new composition for stimulating mitochondrial function.

Patent Protected (USA) – NRGBiotic

A new composition for stimulating mitochondrial function.

Patent Protected – EnBiotic

A probiotic and enzyme containing compositions and uses thereof.

Medlab has multiple patents pending on our products:

Provisional Patent – ImmuneBiotic

A new composition for heightening the innate immune system.

Provisional Patent – Biologics/Chronic Kidney Disease

A new composition for the prophylactic treatment of kidney disease and/or improving kidney function.

Provisional Patent – Biologics/Cannabinoids

A new composition for the treatment of phrophylaxis of pain with secondary effects for the treatment of nausea and bulimia.

Provisional Patent – Biologics/Muscular/Skeletal Ageing

A new composition for the treatment or prevention of muscle degeneration associated with age-related or injury-related muscle weakness or atrophy.

Provisional Patent – Biologics/Depression – Orotate

A new composition for the treatment or prevention of mild to moderate depression, or a depressive/anxiety disorder.

Provisional Patent (USA) – Nanocelle

Oral and/or nasal transmuscosal delivery systems.

Provisional Patent – ORSBiotic

Probiotic compositions for rehydration.

Provisional Patent – GastroDaily

Yeast-containing compositions for gastrointestinal health.

Provisional Patent – Biologics/Obesity

A new composition for the treatment of metabolic syndrome and obesity.

Provisional Patent – Nanocelle (fat sol statin)

Oral and/or nasal transmucosal delivery systems.

Provisional Patent – AscorBiotic – In Draft

A new composition for the delivery and uptake of vitamin C in humans.

Provisional Patent – Lactose Intolerance – In Draft

A new composition for nutritional and therapeutic compositions and methods.

2015:

Vitetta L, Hall S, Coulson S. Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences. Microorganisms 2015;3(4):913-932.

Schloss J, Colosimo M, Vitetta L. New Insights into potential prevention and management options for chemotherapy-induced peripheral neuropathy: Asia-Pacific Journal of Oncology Nursing 2015 Dec: 10.4103/2347-5625.170977

Schloss J, Colosimo M, Airey C, Vitetta L.  Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency. Support Care Cancer 2015 Jul;23(7):1843-50

Schloss J, Colosimo M, Vitetta L. Herbal Medicines and Chemotherapy Induced Peripheral Neuropathy (CIPN): a Critical Literature Review.Crit Rev Food Sci Nutr. 2015 Apr 7:0.

Marx W, Ried K, McCarthy AL, Vitetta L. Sali A, McKavanagh D, Isenring E. Ginger-Mechanism of Action in Chemotherapy-induced Nausea and Vomiting: A Review. Crit Rev Food Sci Nutr. 2015 Apr 7:0.

Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a Specialized Trigonella foenum graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytotherapy Research 2015.

Bambling M, Edwards SC, Coulson S, Vitetta L. S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults; a pilot study. Journal of Advances in Integrative Medicine. 2015. 2, (1). 56–62

2014:

Vitetta L, Bambling, M, Alford H.  The gastrointestinal tract microbiome, probiotics and mood. Inflammopharmacology 2014; doi:10.1007/s10787-014-0216-x.

Vitetta L, Manuel R, Zhou JY, Linnane A, Hall S, Coulson S. The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.  Pharmaceuticals 2014; 7(9): 954-89.

Vitetta LBriskey B, Alford H, Hall S, Coulson S. Probiotics, prebiotics and the gastrointestinal tract in health and diseaseInflammopharmacology 2014; 22(3): 135-154.

Gray B, Vitetta L, Davies WP. Liver function parameters, cholesterol, and phospholipid α-linoleic acid are associated with adipokine levels in overweight and obese adults. Nutrition Research 2014; 345: 375-382.

Scholoss, J, Vitetta L. Antioxidants to Abrogate Free Radicals.  New insights to challenge currently held beliefsAustralian Journal of Herbal Medicine 2014; 26(1): 4-6.

Vitetta L, Linnane AW.  Endocellular Regulation of Free Radicals and Hydrogen Peroxide: Key Determinants of the Inflammatory ResponseInflammopharmacology 2014; 22(2):69-72.

Bella C, Coulson S, Vitetta L. Is co–prescribing a multi–strain probiotic the simple solution for treating and preventing Proton Pump Inhibitor (PPIs) induced Clostridium difficile Associated Diarrhoea (CDAD) while maintaining evidence based pharmacotherapy? Advances in Integrative Medicine 2014; 1(1): 52-54.

Shing C, Peake J, Lim C, Briskey D, Walsh N, Fortes M, Ahuja K, Vitetta L. Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heatEuropean Journal of Applied Physiology 2014; 114(1):93-103.

Vitetta L, Hall S, Linnane AW. Live Probiotic Cultures and the Gastrointestinal Tract: Symbiotic Preservation of Tolerance Whilst Attenuating Pathogenicity. Front Cell Infect Microbiol 2014; doi: 10.3389/fcimb.2014.00143.

2013:

Gray B, Steyn F, Davies P, Vitetta L. Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity managementEuropean Journal of Clinical Nutrition 2013; 67(12):1234-42.

Schloss JM,Colosimo M, Airey C, Vitetta L. Nutraceuticals and Chemotherapy Induced Peripheral Neuropathy (CIPN): a Systematic Review. A systematic review. Clinical Nutrition 2013; 32(6): 888-893.

Vitetta L, Linnane A, Gobe G.  From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical SignalingToxins 2013; 5(11): 2042-2057.

Vitetta L, Alford H. The Pharmacobiotic Potential of the Gastrointestinal Tract Micro-Biometabolome–Probiotic Connect: A Brief CommentaryDrug Development Research 2013; 74(6): 353-359.

Marx W, Teleni L, McCarthy A, Vitetta L, McKavanagh D, Thomson T, Isenring E. Ginger (Zingiber officinale) and chemotherapy-induced nausea and vomiting: a systematic literature reviewNutrition Reviews 2013; 71(4): 245-254.

Palacios T, Coulson S, Butt H, Vitetta L. The Gastrointestinal Microbiota and Multi-Strain Probiotic Therapy:  In Children and Adolescent ObesityAdvances in Integrative Medicine 2013; 1(1): 2-8.

Vitetta L, Couslon S, Linnane A, Butt H.  The Gastrointestinal Microbiome and Musculoskeletal Diseases: A beneficial Role for probiotics and prebioticsPathogens 2013; 2(4): 606-626. 

Vitetta L, Gobe G. Uremia and Chronic Kidney Disease: The Role of Probiotics / PrebioticsMolecular Nutrition & Food Research 2013; 57(5): 824-832.

2015:

Vitetta L & Coulson S, Live Probiotic Cultures and the Gastrointestinal Tract – Improving More Than Just GI Health, General Practice Conference and Exhibition [Sydney, Melbourne] 2015. 

Vitetta L & Coulson S, High Fat Diet, Probiotics and Non–Alcoholic Fatty Liver Disease, General Practice Conference and Exhibition [Sydney, Melbourne] 2015. 

Vitetta L & Coulson S, Depression and the Gut Microbiome Influence of Probiotics and Nutraceuticals,General Practice Conference and Exhibition [Sydney, Melbourne] 2015. 

Vitetta L & Coulson S, Diarrhoeal Illness: Causes and Evidenced Based Treatments, General Practice Conference and Exhibition [Sydney, Melbourne] 2015. 

Coulson S, Inter–Kingdom communication: bacterial instruction of host gene expression, The 5th Science of Nutrition in Medicine and Healthcare Conference 2015. 

Vitetta L, A multi-strain probiotic preparation in a mouse model of a high fat diet / obesity induced liver steatosis, The 5th Science of Nutrition in Medicine and Healthcare Conference 2015. 

Vitetta L & Coulson S, Probiotics in Clinical Practice and ICU, 16th Annual Meeting: Australian College of Critical Care Nurses 2015. 

Vitetta L. Gut Function and Chronic Kidney Disease. National Institute of Integrative Medicine 1st Symposium, 2015. 

Coulson S. Neonatal and Infant Development: Influence of Bacteria. National Institute of Integrative Medicine 1st Symposium, 2015. 

Vitetta L. Reactive oxygen species and their lifelong regulation of the metabolome. 6th World Congress on Targeting Mitochondria. Oct 28–30, 2015. Berlin, Germany, 2015. 

Briskey D, Peake J, Coulson S, Vitetta L. High Fat Diet, Probiotics and Non–Alcoholic Fatty Liver Disease 4th Beneficial Microbes Conference, The Hague, Netherlands, 2015. 

2014:

Hall S. Probiotics for the Gastrointestinal Tract (GIT) Microbiome: The Evidence–Based Market Leader. 4th Annual Symposium of Drug Delivery System 2014; November 18-20. Suzhou, China. 

Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L.  A Randomised Placebo-Controlled Clinical Trial Assessing The Efficacy And Safety Of Supplementation With B Vitamins To Reduce The Incidence Of Chemotherapy-Induced Peripheral Neuropathy [Cipn], Final Results.  4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

Palacios T, Coulson S, Butt H, Vitetta L.  The Effect Of Microbiota-Based Interventions And Metformin In Metabolic And Inflammatory Biomarkers In Adults With Type 2 Diabetes Mellitus (T2DM).  4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

Marx W, McCarthy AL, Ried K, Vitetta L, McKavanagh D, Thomson D, Sali A, Isenring L. Ginger–Mechanism Of Action In ChemotherapyInduced Nausea And Vomiting: A Review. 4th International Conference on the Science of Nutrition in Medicine and Healthcare. 2014; May 3-5. Gold Coast, Australia.

Vitetta L.  The gastrointestinal tract microbiome and the metabolism of herbal compounds such as trigonella foenum-graecum extract.  The 4th International Symposium on Curry and Spice (April 24, 2014) in Seoul, South Korea.

Vitetta L.  Probiotics, the gastrointestinal tract microbiome and musculoskeletal diseases. International Probiotic Association World Congress.  May 9-10, 2014, Athens, Greece.  In: Beneficial Microbes 5 (suppl 1): 23.

Vitetta L. Gut Bacteria and Health…Probiotics and the Microbiome. National Institute of Integrative Medicine 2nd Symposium

2013:

Hall S, Vitetta L. The Importance of Translational Research in Complementary and Alternative Medicines (CAMs); ARCs; Sydney, Australia. June 5 2013.

Palacios T, Coulson S, Butt H, Leong G, Dahiya R, Vitetta L. Gut Microbiota and Metabolic Syndrome: How a Multi-Strain Probiotic may Influence Biomarkers in Obese Adolescents. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

Coulson S, Palacios T, Butt H, Leong G, Dahiya R, Vitetta L. The Role of Gut Microbiota in Non-Alcoholic Fatty Liver Disease: The Efficacy of a Multi-Strain Probiotic in Obese Adolescents. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

Steels E, Rao A,Coulson S, Vitetta L. A phase II randomised double–blind placebo–controlled clinical trial investigating the efficacy and safety of a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

Schloss J, Colosmio M, Linnane AW, Masci P, Vitetta L. B Vitamin Status In Cancer Patients Administered Chemotherapy. 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

Marx W, Ried K, Sali A, Teleni L, McCarthy A, Vitetta L, McKavanagh D, Thomson D, Isenring E. Is Ginger Supplementation Effective In Ameliorating Chemotherapy-Induced Nausea And Vomiting? 3rd International Conference on the Science of Nutrition in Medicine and Healthcare. 2013; May 3-5. Sydney Australia.

Coulson S, Palacios T, Vitetta L.  Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health ConditionsIn: Progress in Drug Research Novel Natural Products: Therapeutic Effects in Pain, Arthritis And Gastro-Intestinal Diseases [Editors: KD Rainsford, MC Powanda and MW Whitehouse] Publisher:Springer Basel AG. 2015. ISBN 9783-0348-0926-9

Vitetta L, Alford H, Palacios T Coulson S.  Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End–Organ Physiology. In: Progress in Drug Research Novel Natural Products: Therapeutic Effects in Pain, Arthritis And Gastro-Intestinal Diseases [Editors: KD Rainsford, MC Powanda and MW Whitehouse] Publisher:Springer Basel AG. 2015. ISBN 9783-0348-0926-9

What is Micellization?

Why is Vitamin D3 Important?

Contact Us

We would love to hear from you.

EMAIL

hello@inmedtech.co

CALL

+1800 921 1710

CONNECT

InMed Technologies
30021 Tomas Rd, Suite 150
Rancho Santa Margarita, CA 92688

Your Name (required)

Your Email (required)

Subject

Your Message